Cardiff has a cash runway of 5-6 quarters, but will need additional funding, potentially leading to significant shareholder ...

AstraZeneca’s Tagrisso could face some serious competition as a first-line targeted therapy for advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC), in the shape of a new two ...

With Wolf Hall returning to the small screen this week, I predict a sudden revival of the Tudor aesthetic. Sadly, I don’t ...

Gee willikers, that sounds really bad. In the face of all the terrible visuals and creepy stalker-guy rhetoric, the former ...

If the split is approved by shareholders, former Paramount Global CEO Bob Bakish would be one of 12 board members of Canal+ ...

The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of datopotamab deruxtecan (Dato-DXd)- ...

In Southern California, storm preparations follow after major wildfires. That's what San Bernardino crews are now doing -- ...

Researchers found no significant differences in response or survival outcomes between patients with dMMR and pMMR endometrial cancer.

The Move More toddler play service provided by Jersey Sport will end next month following a decision to axe its funding. | ...

Phase 3 pivotal trial underway evaluating RMC-6236 in patients with metastatic pancreatic ductal adenocarcinoma (PDAC), supported by compelling ...

Revolution Medicines, Inc. (NASDAQ: RVMD) Q3 2024 Earnings Call Transcript November 6, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-0.94 EPS, expectations were ...

"We are adding a trash rack to the bottom of it so that when any debris flow that may come in, it's filtered out and allows the water to go on through and out the channel," said David Doublet ...